Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUS NYSE:ARDT NASDAQ:CELC NYSE:PACS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$110.92-1.1%$112.46$88.96▼$136.72$2.06B0.81165,823 shs91,126 shsARDTArdent Health$14.19-0.6%$14.00$11.31▼$20.72$2.03BN/A380,634 shs296,884 shsCELCCelcuity$13.63+0.1%$11.76$7.58▼$19.77$515.74M0.45275,957 shs171,535 shsPACSPACS Group$12.64-1.2%$11.31$8.28▼$43.92$1.95B0.92806,590 shs416,970 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-1.14%-0.84%-1.57%+9.99%-6.62%ARDTArdent Health-0.63%+6.16%+6.54%+20.66%+1,418,999,900.00%CELCCelcuity+0.07%-1.16%+9.13%+47.67%-19.11%PACSPACS Group-1.17%-3.81%+18.83%+38.60%-58.12%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.9776 of 5 stars3.64.00.05.03.52.53.1ARDTArdent Health3.3555 of 5 stars3.50.00.00.02.20.03.1CELCCelcuity2.2861 of 5 stars3.61.00.00.03.22.50.0PACSPACS Group2.8155 of 5 stars3.41.00.00.02.20.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5728.54% UpsideARDTArdent Health 3.00Buy$20.6745.64% UpsideCELCCelcuity 3.17Buy$28.40108.36% UpsidePACSPACS Group 2.86Moderate Buy$34.29171.25% UpsideCurrent Analyst Ratings BreakdownLatest CELC, ADUS, PACS, and ARDT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/1/2025CELCCelcuityStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$30.006/30/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.006/20/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.006/10/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$133.005/20/2025ARDTArdent HealthStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$21.00 ➝ $21.005/19/2025CELCCelcuityHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$27.00 ➝ $27.005/15/2025ARDTArdent HealthRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$21.00 ➝ $21.005/15/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.00 ➝ $29.005/9/2025ARDTArdent HealthGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$16.00 ➝ $18.005/8/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.004/22/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.00(Data available from 7/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.77$5.33 per share20.82$53.52 per share2.07ARDTArdent Health$6.02B0.34$2.52 per share5.62$10.66 per share1.33CELCCelcuityN/AN/AN/AN/A$3.11 per shareN/APACSPACS Group$3.11B0.62N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.4325.0420.691.596.52%9.23%6.96%8/4/2025 (Estimated)ARDTArdent Health$210.34M$1.638.717.241.293.73%16.07%4.69%8/13/2025 (Estimated)CELCCelcuity-$111.78M-$3.03N/AN/AN/AN/A-96.21%-49.44%8/13/2025 (Estimated)PACSPACS Group$112.87MN/A0.007.10N/AN/AN/AN/AN/ALatest CELC, ADUS, PACS, and ARDT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2025Q2 2025ADUSAddus HomeCare$1.45N/AN/AN/A$345.71 millionN/A5/14/2025Q1 2025CELCCelcuity-$0.95-$0.86+$0.09-$0.86N/AN/A5/6/2025Q1 2025ARDTArdent Health$0.21$0.29+$0.08$0.29$1.50 billion$1.50 billion5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AARDTArdent HealthN/AN/AN/AN/AN/ACELCCelcuityN/AN/AN/AN/AN/APACSPACS GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.201.741.74ARDTArdent Health0.702.121.98CELCCelcuity1.146.616.61PACSPACS GroupN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%ARDTArdent HealthN/ACELCCelcuity63.33%PACSPACS GroupN/AInsider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%ARDTArdent Health1.70%CELCCelcuity15.77%PACSPACS GroupN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.40 million17.55 millionOptionableARDTArdent Health24,900143.04 million140.61 millionOptionableCELCCelcuity4037.87 million31.90 millionOptionablePACSPACS Group32,433152.40 millionN/AOptionableCELC, ADUS, PACS, and ARDT HeadlinesRecent News About These CompaniesNew anti-Mamdani PAC looks to raise $25MJuly 11 at 11:11 AM | crainsnewyork.comCSenate Republican PAC surpasses record by raising $85 million in first six months of off-yearJuly 9 at 2:20 AM | justthenews.comJNorthern Ireland engineering group sold to investorJuly 8, 2025 | insidermedia.comIConservative group takes on IRS a decade after Obama-era scandal and ‘vague’ standardJuly 8, 2025 | bizpacreview.comBWhich will be strongest conference in Group of Six in 2026? Comparing the Pac-12 to the AACJuly 8, 2025 | commercialappeal.comCBelfast-based engineering group PAC acquired by Watford-based investorJuly 8, 2025 | msn.comCorporate money falls flat in council races despite record $14M spentJuly 3, 2025 | crainsnewyork.comCKentucky ’26 Senate race already sees attack ads, PAC spending in GOP primaryJuly 2, 2025 | msn.comPAC Spending in Council Races More Than Doubled, Fueled by Money from DoorDash, Airbnb and UberJuly 2, 2025 | msn.comGroup claims 'gamefowl' PAC leaders seen on secret video at rural Oklahoma cockfightJuly 1, 2025 | tennessean.comTRepublicans face a ferocious ad campaign surrounding Trump’s ‘big, beautiful bill’June 29, 2025 | msn.comWhy the Pac-12 is adding Texas State, how it rebuilt and next steps in realignmentJune 27, 2025 | nytimes.comPACS Group Inc Ownership - MorningstarJune 27, 2025 | morningstar.comMPACS Group Inc Executives - MorningstarJune 25, 2025 | morningstar.comMWith $25 Million, Pro-Cuomo Super PAC Shatters Outside Spending RecordsJune 25, 2025 | nytimes.comAugust 15th Options Now Available For PACS GroupJune 20, 2025 | nasdaq.comPACS Group (NYSE:PACS) Shares Gap Down - What's Next?June 18, 2025 | marketbeat.comPACS Group, Inc. (PACS) Opinions on Financial Restatement and Audit UpdateJune 18, 2025 | quiverquant.comQStrength Seen in PACS Group, Inc. (PACS): Can Its 21.8% Jump Turn into More Strength?June 18, 2025 | zacks.comAssenagon Asset Management S.A. Grows Holdings in PACS Group, Inc. (NYSE:PACS)June 18, 2025 | marketbeat.comSuper PACs Push Up Price of New Jersey Governor ElectionJune 17, 2025 | brennancenter.orgBNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCELC, ADUS, PACS, and ARDT Company DescriptionsAddus HomeCare NASDAQ:ADUS$110.92 -1.28 (-1.14%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$110.88 -0.05 (-0.04%) As of 07/11/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Ardent Health NYSE:ARDT$14.19 -0.08 (-0.56%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$14.18 -0.01 (-0.11%) As of 07/11/2025 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Celcuity NASDAQ:CELC$13.63 +0.01 (+0.07%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$13.71 +0.08 (+0.59%) As of 07/11/2025 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.PACS Group NYSE:PACS$12.64 -0.15 (-1.17%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$12.67 +0.03 (+0.24%) As of 07/11/2025 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/07 - 07/11 Power Solutions International Poised for 75% Upside The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? Super Micro Computer: The Hidden Winner of Soaring Copper Tariffs Nebius Group: Up 385%, Analysts Say It’s Still a Bargain Broadcom Stock: HSBC Sets $400 Target on AI Growth Potential BigBear.ai: Why a 90% Rally Could Be Just the Start Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
